Development of a new type of protease inhibitors, efficacious against FIV and HIV variants

T Lee, VD Le, D Lim, YC Lin, GM Morris…

Index: Journal of the American Chemical Society, , vol. 121, # 6 p. 1145 - 1155

Full Text: HTML

Citation Number: 68

Abstract

... Journal of the ... Contribution from the Department of Chemistry and the Skaggs Institute for Chemical Biology and the Department of ... 1999, 121 (6), pp 1145–1155. DOI: 10.1021/ja982893p. Publication Date (Web): February 3, 1999. Copyright © 1999 American Chemical Society. ...

Related Articles:

Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

[Parkes, Kevin E. B.; Bushnell, David J.; Crackett, Peter H.; Dunsdon, Stephen J.; Freeman, Andrew C.; et al. Journal of Organic Chemistry, 1994 , vol. 59, # 13 p. 3656 - 3664]

Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains

[Journal of Medicinal Chemistry, , vol. 46, # 9 p. 1764 - 1768]

Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

[Parkes, Kevin E. B.; Bushnell, David J.; Crackett, Peter H.; Dunsdon, Stephen J.; Freeman, Andrew C.; et al. Journal of Organic Chemistry, 1994 , vol. 59, # 13 p. 3656 - 3664]

Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

[Journal of Organic Chemistry, , vol. 59, # 13 p. 3656 - 3664]

The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitors

[Journal of Medicinal Chemistry, , vol. 37, # 8 p. 1177 - 1188]

More Articles...